I | Completed | ||
Merck | May 01, 2005 | ||
MRKAd5 HIV-1 gag/pol/nef,MRKAd5+6 HIV-1,MRKAd6 | Ad5 Gag,pol,nef; Ad5 & Ad6 Nef, gag, pol B; Ad6 Gag,pol,nef B | ||
MRKAd5 HIV-1 gag/pol/nef | Viral Vector - Adeno | ||
MRKAd6 | Viral Vector - Adeno | ||
MRKAd5+6 HIV-1 | Viral Vector - Adeno | ||
USA | 146 | ||
NCT00850616 | |||
http://clinicaltrials.gov/ct2/show/NCT00850616 |